港彩开奖

Australian oncology specialist, Icon Group takes first steps in UK market with takeover of Pharmaxo Group聽 Icon is aiming to help close gaps in access to cancer medications in the UK through its acquisition of the Wiltshire-based compounder. 聽 Announcing the deal, Mark Middleton, Icon鈥檚 chief executive, said the acquisition reflected the company鈥檚 鈥渙ngoing commitment